Dupilumab (Dupixent®, Sanofi Biotechnology, Paris, France) is a fully human IgG4 monoclonal antibody that works through selective binding to IL-4Rα, effectively suppressing type 2 inflammation and relieving symptoms of AD [54,55]. Here, IL4R is linked to Alzheimer disease.